MANDARIN (S6371)

· Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MANDARIN (S6371), covering 2026-04-08 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Update: MANDARIN (S6371) [Phase 3]